31 March 2022
Braveheart Investment Group plc
("Braveheart", the "Company" or the "Group")
Result of General Meeting
Braveheart Investment Group plc (AIM: BRH), the fund management and strategic investor group, announces that, at the General Meeting of the Company held earlier today, the resolution put to shareholders giving the directors authority to allot shares generally was approved but the resolution to grant the directors authority to allot shares for cash on a non-pre-emptive basis was not approved.
Accordingly, shareholder permission has been received to authorise the directors unconditionally, for the purposes of Section 551 of the Companies Act 2006 (the "CA 2006"), to allot or grant rights to subscribe for shares in the Company up to an aggregate nominal amount of £400,000 or 20,000,000 ordinary shares of 2 pence each, although not for cash on a non-pre-emptive basis.
The results of the proxy voting are outlined in the table below and will be available on the Company's website braveheartgroup.co.uk in due course.
| RESOLUTIONS | NO OF VOTES FOR | % OF VOTES CAST (EXCLUDING VOTES WITHELD) | NO OF VOTES AGAINST | % OF VOTES CAST (EXCLUDING VOTES WITHELD) | TOTAL VOTES CAST (EXCLUDING VOTES WITHHELD) | NO OF VOTES WITHHELD |
| Ordinary Business | ||||||
| 1) to authorise the directors to replace the existing authority to allot shares in the Company in connection with s551 of the Companies Act 2006 | 8,247,777 | 70.70 | 3,418,326 | 29.30 | 11,666,103 | 2,658 |
| Special Business | ||||||
| 2) to authorise the directors to allot Relevant Securities as if s561 of the Companies Act 2006 did not apply | 8,246,004 | 71.92 | 3,220,099 | 28.08 | 11,466,103 | 202,658 |
For further information:
| | |
| Braveheart Investment Group plc | Tel: 01738 587555 |
| Trevor Brown CEO | |
| | |
| Allenby Capital Limited (Nominated Adviser and Joint Broker) | Tel: 020 3328 5656 |
| David Worlidge / James Reeve / George Payne | |
| | |
| Peterhouse Capital Limited (Joint Broker) | Tel: 020 7469 0936 |
| Heena Karani / Lucy Williams | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
